These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 6732757

  • 1. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E, Markwardt F.
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF, Herman AG.
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [Abstract] [Full Text] [Related]

  • 4. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL, El Mouelhi M, Pfannkuche HJ, Rose K, Marro M, Angiolillo DJ.
    Am J Ther; 2010 Feb; 17(6):543-52. PubMed ID: 19797939
    [Abstract] [Full Text] [Related]

  • 5. Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits.
    Takano S.
    Arch Int Pharmacodyn Ther; 1995 Feb; 330(3):297-308. PubMed ID: 8836449
    [Abstract] [Full Text] [Related]

  • 6. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B, Hefez A, Youdim MB.
    Prog Biochem Pharmacol; 1980 Feb; 16():119-32. PubMed ID: 7443729
    [Abstract] [Full Text] [Related]

  • 7. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F, Xhonneux B, Leysen J, Janssen PA.
    Thromb Res; 1984 Feb 01; 33(3):305-21. PubMed ID: 6710435
    [Abstract] [Full Text] [Related]

  • 8. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T, Lie RT, Holmsen H.
    Undersea Biomed Res; 1989 Nov 01; 16(6):453-64. PubMed ID: 2603242
    [Abstract] [Full Text] [Related]

  • 9. Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine.
    Kitazawa T, Kubo O, Satoh M, Taneike T.
    Br J Pharmacol; 1998 Jan 01; 123(2):173-82. PubMed ID: 9489604
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH, Briejer MR, Schuurkes JA.
    Br J Pharmacol; 1997 Feb 01; 120(4):714-20. PubMed ID: 9051313
    [Abstract] [Full Text] [Related]

  • 11. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML, Robertson DW, Bloomquist WE, Wilson HC.
    J Pharmacol Exp Ther; 1992 Apr 01; 261(1):202-8. PubMed ID: 1560366
    [Abstract] [Full Text] [Related]

  • 12. Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists.
    Sternberg EM, Trial J, Parker CW.
    J Immunol; 1986 Jul 01; 137(1):276-82. PubMed ID: 2423604
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F, David JL, Janssen PA.
    Agents Actions; 1982 Jul 01; 12(3):388-97. PubMed ID: 6215842
    [Abstract] [Full Text] [Related]

  • 14. Effect of verapamil on platelet aggregation.
    Glusa E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Jul 01; 115(4):469-73. PubMed ID: 2465955
    [Abstract] [Full Text] [Related]

  • 15. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F, Motamed M.
    Br J Pharmacol; 1976 Feb 01; 56(2):209-18. PubMed ID: 1252669
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
    Kekewska A, Görnemann T, Jantschak F, Glusa E, Pertz HH.
    J Pharmacol Exp Ther; 2012 Feb 01; 340(2):369-76. PubMed ID: 22049464
    [Abstract] [Full Text] [Related]

  • 18. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F, Xhonneux B, Tollenaere JP, Janssen PA.
    Thromb Res; 1985 Dec 01; 40(5):581-96. PubMed ID: 2935970
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY, Bai Y, Li WH.
    Zhongguo Yao Li Xue Bao; 1998 Jan 01; 19(1):58-62. PubMed ID: 10375761
    [Abstract] [Full Text] [Related]

  • 20. The effect of ethanol on some serotonergic mechanisms in rat blood platelets.
    Chabielska E, Pietraszek M, Malinowska B, Buczko W.
    Pol J Pharmacol Pharm; 1988 Jan 01; 40(3):241-9. PubMed ID: 3241765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.